Ann Neurol

1. JIANG X, O'Bryant SE, Rissman RA, Johnson LA, et al
   Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers.
   Ann Neurol. 2026 May 4. doi: 10.1002/ana.78238.
   

   >> Share

   
   

   
   Ann Nucl Med

2. KITAMURA T, Kawaguchi N, Matsuoka M, Matsumoto K, et al
   Clinical significance of suspicious incidental FDG uptake: a comparison between digital PET/CT and conventional PET/CT.
   Ann Nucl Med. 2026 Jul 24. doi: 10.1007/s12149-026-02264.
   

   >> Share

   
   
3. TAKAHASHI M, Pairodsantikul P, Watabe H, Shidahara M, et al
   Impact of posture change on patient-specific absorbed dose estimation in nuclear medicine.
   Ann Nucl Med. 2026 Jul 23. doi: 10.1007/s12149-026-02263.
   

   >> Share

   
   
4. SEKER K, Yilmaz M, Erdis E, Hasbek Z, et al
   Development of a (18)F-FDG PET/CT-based radiomic risk score as an independent prognostic factor in small cell lung cancer.
   Ann Nucl Med. 2026 Jul 20. doi: 10.1007/s12149-026-02261.
   

   >> Share

   
   

   
   Appl Radiat Isot

5. ALUICIO-SARDUY E, Wehner LE, Jeffery JJ, Levitt NP, et al
   Cyclotron production of (206)Bi for SPECT tracing of bismuth radioisotopes' redistribution in vivo.
   Appl Radiat Isot. 2026;237:112822.
   

   >> Share

   
   
6. LI Y, Wang S, Xia W, Li Z, et al
   Development and calibration of a passive sampler for monitoring airborne (131)I in nuclear medicine facilities.
   Appl Radiat Isot. 2026;237:112803.
   

   >> Share

   
   

   
   Circ Cardiovasc Imaging

7. TERSALVI G, Bois MC, Scott CG, Carey P, et al
   Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy.
   Circ Cardiovasc Imaging. 2026 Jul 23:e019832.
   

   >> Share

   
   
8. HART P, Jawaid A, Fitch J, Aerton NP, et al
   Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy.
   Circ Cardiovasc Imaging. 2026 Jul 23:e019747.
   

   >> Share

   
   
9. MARCINKIEWICZ AM, Shanbhag A, Chareonthaitawee P, Zhang W, et al
   Automated AI-Based Aortic Measurements From Attenuation Correction CT as an Adjunctive Cardiovascular Risk Biomarker: An International Multicenter Study.
   Circ Cardiovasc Imaging. 2026 Jul 2:e019726. doi: 10.1161/CIRCIMAGING.125.019726
   

   >> Share

   
   

   
   Circulation

10. LEHTONEN J, Birnie DH
    Diagnostic Approach to Cardiac Sarcoidosis.
    Circulation. 2026;154:288-295.
    

    >> Share

    
    
11. LOPEZ DM, Brown JM, Divakaran S, Huck DM, et al
    Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal Perfusion.
    Circulation. 2026;154:212-222.
    

    >> Share

    
    

    
    Clin Nucl Med

12. LI Y, Zhang H, Xiong Y, Fan Y, et al
    18F-FDG and 68Ga-Pentixafor PET/CT in a Patient With Castleman Disease.
    Clin Nucl Med. 2026 Jul 8. doi: 10.1097/RLU.0000000000006603.
    

    >> Share

    
    

    
    J Neurol Neurosurg Psychiatry

13. LIU M, Zhang Z, Fan S, Bai L, et al
    Pet hamster exposure is associated with autoimmune cerebellar ataxia: a hospital-based case-control study.
    J Neurol Neurosurg Psychiatry. 2026 Jul 20:jnnp-2026-339193.
    

    >> Share

    
    

    
    J Nucl Med

14. GELARDI F, Pini C, Sollini M, Chiti A, et al
    PET Never Lies: Healthy Organ Uptake Beyond Tumor Expression in Theranostic Applications.
    J Nucl Med. 2026 Jul 23:jnumed.126.272839. doi: 10.2967/jnumed.126.272839.
    

    >> Share

    
    
15. PARIHAR AS, Dehdashti F, Pant N, Ravindra SG, et al
    Evaluating Interim Progression: First Posttherapy (177)Lu-PSMA SPECT/CT Relative to Baseline PSMA PET/CT.
    J Nucl Med. 2026 Jul 23:jnumed.126.272545. doi: 10.2967/jnumed.126.272545.
    

    >> Share

    
    
16. BOURSIER C, Heyer S, Zouaoui A, Roth N, et al
    Evaluation of 9-Minute Dual-Energy Peak Time-Reduced 360 degrees CZT Total-Body [(177)Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [(68)Ga]Ga-PSMA PET.
    J Nucl Med. 2026 Jul 23:jnumed.126.272647. doi: 10.2967/jnumed.126.272647.
    

    >> Share

    
    
17. KARIMZADEH A, Futterer C, Hansen K, Coban O, et al
    Outcome Prediction After [(177)Lu]Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: External Validation of a [(68)Ga]Ga-PSMA-11 PET-Based Model with [(18)F]F-Flotufolastat.
    J Nucl Med. 2026 Jul 23:jnumed.125.270944. doi: 10.2967/jnumed.125.270944.
    

    >> Share

    
    
18. ZHU W, Huo L
    Reply: PET Never Lies: Healthy Organ Uptake Beyond Tumor Expression in Theranostic Applications.
    J Nucl Med. 2026 Jul 23:jnumed.126.273362. doi: 10.2967/jnumed.126.273362.
    

    >> Share

    
    

    
    Nuklearmedizin

19. BOSBACH WA, Manser V, Bregenzer CM, Gozlugol N, et al
    FDG-PET/CT in children with malignant diseases - comparison of a long axial field of view scanner with a standard scanner.
    Nuklearmedizin. 2026 Jul 23. doi: 10.1055/a-2912-4818.
    

    >> Share

    
    

    
    Phys Med Biol

20. YUAN Y, Cui M, Diao Z, Tong G, et al
    CED-Diff: a clinically-experience-driven diffusion model with differentiated feature extraction for head and neck tumour PET/CT segmentation.
    Phys Med Biol. 2026 Jul 21. doi: 10.1088/1361-6560.
    

    >> Share

    
    
21. YAZDANI E, Manafi-Farid R, Karamzade-Ziarati N, Salimi Y, et al
    Dosimetry and pharmacokinetics of [(223)Ra]Ra-dichloride alpha therapy in prostate cancer patients with bone metastases.
    Phys Med Biol. 2026;71.
    

    >> Share

    
    

    
    PLoS One

22. ZHANG Y, Yu Y, Ge B, Gong D, et al
    Integrated computational analysis identifies FABP4, PTGS2, and HPGD as Key molecular targets linking PET microplastic exposure to metabolic dysfunction-associated steatotic liver disease.
    PLoS One. 2026;21:e0354607.
    

    >> Share

    
    
23. LEE Y, Kim S, Kim S, Kang Y, et al
    Feature integration of [18F]FDG PET brain imaging using deep learning for sensitive cognitive decline detection.
    PLoS One. 2026;21:e0341995.
    

    >> Share

    
    

    
    Semin Nucl Med

24. PANT V, Malasani V, Dash S, Nagaraj C, et al
    Nuclear medicine in paediatric tumours: current status and focus on theranostics.
    Semin Nucl Med. 2026 Jul 23:S0001-2998(26)00141.
    

    >> Share

    
    
25. CURRIE GM, Rohren EM
    Can AI Make Paediatric PET/CT Lower Dose? Opportunities, Evidence and Cautions.
    Semin Nucl Med. 2026 Jul 21:S0001-2998(26)00140.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share